Immutep Limited (IMMP)
IMMP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-06-30, https://www.sec.gov/Archives/edgar/data/1506184/000119312525249346/0001193125-25-249346-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2025-06-30. Converted from AUD at 1.4266 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | IMMP on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Australia |
| IPO year | Not reported by the screener |
| SEC CIK | 0001506184 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | C3 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $7.2M |
| Net income | -$43.1M |
| Operating income | Not in SEC XBRL data |
| Net margin | -594.6% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.6× |
Reported in AUD; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | F-3 | 2023-04-28 |
| Latest annual report | 20-F | 2025-10-24 |
| Latest quarterly / interim | 6-K | 2026-10-14 |
Source: SEC EDGAR submissions feed, 733 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ABVC | ABVC BioPharma Inc. | $0.9790 | -0.08% | $26.1M |
| ATOS | Atossa Therapeutics Inc. | $2.56 | +7.17% | $25.5M |
| MCRB | Seres Therapeutics Inc. | $2.53 | -5.60% | $25.4M |
| CNTX | Context Therapeutics Inc. | $0.2750 | -9.84% | $25.3M |
| IGC | IGC Pharma Inc. | $0.2650 | -3.99% | $27.4M |
| BYSI | BeyondSpring Inc. | $0.6067 | -1.43% | $24.9M |
| MIRA | MIRA Pharmaceuticals Inc. | $0.6664 | -5.53% | $28.0M |
| SHPH | Shuttle Pharmaceuticals Holdings Inc. | $5.18 | -4.95% | $24.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier